Genolution Inc. (225220) — Capital Reinvestment Ratio

Latest as of March 2024: 18.57x

Genolution Inc. (225220) has a Capital Reinvestment Ratio of 18.57x as of March 2024, meaning it reinvests 19% of its operating cash flow (₩174.53 Million) in capital expenditures (₩3.24 Billion). See 225220 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

18.57x
Capex / Operating Cash Flow

Operating Cash Flow

₩174.53 Million
KRW

Capital Expenditures

₩3.24 Billion
KRW

Data as of

Mar 2024
Most recent filing

Genolution Inc. Capital Reinvestment Ratio (2017–2022)

This chart tracks Genolution Inc.'s Capital Reinvestment Ratio across 5 annual periods. Check how aggressively does Genolution Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Genolution Inc. (2017–2022)

Year-by-year Capital Reinvestment Ratio for Genolution Inc. from 2017 to 2022. For live market cap and broader valuation context, see market value of Genolution Inc..

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2022 1.66x ₩13.55 Billion ₩22.54 Billion ▲ +734.3%
2021 0.20x ₩25.73 Billion ₩5.13 Billion ▲ +5.6%
2020 0.19x ₩45.97 Billion ₩8.68 Billion ▼ -99.0%
2018 19.82x ₩147.49 Million ₩2.92 Billion ▲ +1549.9%
2017 1.20x ₩717.13 Million ₩861.62 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow